TNF and hepatocellular carcinoma: The testing method was the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), which was used in 8 of those 11 studies they reported that the TNF α -238 G>A polymorphism was significantly associated with increased risk of hepatocellular carcinoma.